Apnimed, Inc. (APMD) Corporate Subsidiaries
Apnimed, Inc. (APMD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APMD
CIK: 1745648
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJames Holmes
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-09-08 | — | S-8 | 0001193125-26-385357 | View SEC Doc Filr Page |
| 10-Q | 2026-09-08 | 2026-06-30 | 10-Q | 0001193125-26-385356 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-385355 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001193125-26-340067 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001104659-26-092032 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0000905148-26-003483 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0000919574-26-004812 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330510 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330505 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330508 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330504 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330507 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330503 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | 4 | 0001193125-26-330506 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-330502 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330509 | View SEC Doc Filr Page |
| S-8 | 2026-07-31 | — | S-8 | 0001193125-26-328744 | View SEC Doc Filr Page |
| 424B4 | 2026-07-31 | — | 424B4 | 0001193125-26-328422 | View SEC Doc Filr Page |
| EFFECT | 2026-07-30 | — | EFFECT Filing | 9999999995-26-002498 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-30 | FORM 3 | 0000905148-26-003420 | View SEC Doc Filr Page |
| S-1MEF | 2026-07-30 | — | S-1MEF | 0001193125-26-326515 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-30 | 3 Filing | 0000919574-26-004695 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-30 | 3 | 0001193125-26-326266 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-30 | 3 | 0001193125-26-326255 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-30 | 3 | 0001193125-26-326223 | View SEC Doc Filr Page |